Proceedings of International Conference on Applied Innovation in IT  ·  2026/03/31  ·  Vol. 14  ·  Issue 1  ·  pp. 901–905
Relationship Between Total Cholesterol, Bmi and Hba1c In Type 2 Diabetes Patients
Khalid H. Gathwan, Sumaiah I. Hussein, Shatha Q. Jawad, Salim J. Attia, Aseel A. Jebur, Suha A. Talal, Muna S. Hashim and Aula. T. Hussein
📄 Download PDF DOI: 10.25673/123652
Abstract
Lipid profile and diabetes type 2 are common disorder in the world. Raised blood glucose results from the underlie creation of insulin or a hardened to the impact of insulin. Diabetes type 2 leads to complication in human body organs, therefore diagnosis of disease in an early stage is very important. The current study was conducted for the purpose of knowing the relationship between blood lipid profile and its correlation with body mass index and calculated among diabetes patients. This study included 70 subject aged 40-50 years, forty patients with diabetes type 2 and thirty as healthy subjects were selected randomly. Blood samples were taken for estimating biochemical parameters such as Body mass index (BMI), Glycated hemoglobin (HbA1c), High Density Lipoprotein Cholesterol (HDL-C), Low Density Lipoprotein Cholesterol (LDL-C), Fasting blood glucose (FBS), Triglycerides (TG), Total cholesterol (TC) and Total oxidant status (TOS ) levels in both groups. The results revealed higher level of body mass, total oxidant status level and parameters of lipid profile in patients with diabetes type 2 in comparison with healthy group, with significant variation except in High Density Lipoprotein Cholesterol, in which there is no significant difference. Diabetes type 2 causes an increased in body mass index, HbA1c and lipid profile (Triglycerides, Total cholesterol, LDL expect HDL there is no differences).
Keywords
Glycated Haemoglobin Total Cholesterol Diabetes Type 2 Oxidative Stress.
References
  1. K. I. Reham, K. G. Kadhim and A. D. Ali, “Early prediction of nephropathy in Iraqi patient with diabetes type II by evaluating some relevant biochemical factors,” Baghdad Sci. J., vol. 21, no. 5, pp. 1549-1560, 2024.
  2. X. Hu, L. Zou, S. Wang, T. Zeng, P. Li, Y. Shen and L. Chen, “Performance of serum angiotensin-converting enzyme in diagnosing sarcoidosis and predicting the active status of sarcoidosis: A meta-analysis,” Biomolecules, vol. 12, no. 10, p. 1400, 2022.
  3. S. M. Khidhir, A. M. Mahmud and I. M. Maulood, “Association of endothelin-I and asymmetric dimethylarginine levels with insulin resistance in type-2 diabetes mellitus patients,” Baghdad Sci. J., vol. 19, no. 1, pp. 55-55, 2022.
  4. “Diabetes,” World Health Organization, 2021, [Online]. Available: https://www.who.int/health-topics/diabetes#tab=tab_1, [Accessed: Mar. 16, 2023].
  5. M. H. Ahmed, A. M. Atta and H. A. Ali, “Lipid profiles and HbA1c level among type 2 diabetes patients in Hilla city, Iraq,” J. Popul. Ther. Clin. Pharmacol., vol. 30, no. 7, pp. e273-e278, 2023, [Online]. Available: https://doi.org/10.47750/jptcp.2023.30.07.033.
  6. L. Prabhat, L. Jagriti, B. Ayan and B. Akash, “Lipoprotein ratio: Correlation with glycated hemoglobin among type 2 diabetes mellitus patients,” Cureus, vol. 16, no. 2, pp. e53665-e53671, 2024, [Online]. Available: https://doi.org/10.7759/cureus.53665.
  7. A. M. Al-Jabri, S. S. Adeb, G. H. Alwan and H. R. Obayes, “Correlation of total cholesterol and glucose in serum of Iraq patients with atherosclerosis and diabetes mellitus type 2,” Eng. & Tech. J., vol. 31, no. 6B, pp. 801-808, 2013.
  8. F. A. Shihab, A. L. Jasim and A. G. Mohammed, “Impact of gliclazide modified release or glimepiride as add-on therapy to metformin on glycemic and oxidative stress parameters in type 2 diabetic patients,” Iraqi J. Pharm. Sci., vol. 33, no. 2, pp. 20-30, 2024.
  9. M. S. Mohammed and H. S. Ahmed, “Urokinase-type plasminogen activator receptor as a predictive marker for cardiac disease among type 2 diabetic patients,” Med. J. Babylon, vol. 20, pp. 750-756, 2023.
  10. J. P. Bhumika, N. M. Dhaval, V. Ansee and P. Keyur, “Correlation of body mass index (BMI) with saliva and blood glucose levels in diabetic and non-diabetic patients,” J. Pharm. Biol. Sci., vol. 15, pp. s1204-s1207, 2023, [Online]. Available: https://doi.org/10.4103/jpbs.jpbs_159_23.
  11. L. Z. Sadiq, “Free radicals and oxidative stress signaling mechanisms, redox basis for human diseases, and cell cycle regulation,” vol. 23, no. 1, pp. 13-35, 2023.
  12. C. M. Volpe et al., “Cellular death, reactive oxygen species (ROS) and diabetic complications,” vol. 9, no. 2, pp. 119-128, 2018.
  13. “Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults,” Arch. Intern. Med., vol. 158, pp. 1855-1867, 1998, doi: 10.1001/archinte.
  14. A. Mohammed, “Correlation between HbA1c and lipid profile in patients with type 2 diabetes mellitus,” Kirkuk J. Med. Sci., vol. 11, no. 1, pp. 101-107, 2023.
  15. M. Naeem, R. M. Khattak, M. Rehman and M. Khattak, “The role of glycated hemoglobin (HbA1c) and serum lipid profile measurements to detect cardiovascular diseases in type 2 diabetic patients,” South East Asia J. Public Health, vol. 2, pp. 30-34, 2016.
  16. I. Bouragba, M. Diaf, S. Souiah and A. Melih, “The association of glycated hemoglobin and lipid profile with peripheral artery disease in metabolic syndrome patients from Northwestern Algeria,” Baghdad Sci. J., vol. 21, no. 9, pp. 2802-2828, 2024.
  17. K. I. Reham, K. G. Kadhim and A. D. Ali, “Studying sex effect on CTGF, TGF-B1 levels and some relevant parameters in Iraqi diabetic patients with glomeruli and renal tubules fibrosis,” IHJPAS, vol. 37, no. 2, pp. 260-269, 2024, [Online]. Available: https://doi.org/10.30526/37.2.3302.
  18. E. M. Mikhael, M. A. Hassali, S. A. Hussain and N. Shawky, “Self-management knowledge and practice of type 2 diabetes mellitus patients in Baghdad, Iraq: A qualitative study,” Diabetes, Metabolic Syndrome and Obesity, vol. 12, pp. 1-17, 2018.
  19. B. I. Patel, B. Dave, D. Dave, P. Karmaker, M. Shah and B. Sarvaiya, “Comparison and correlation of glucose levels in serum and saliva of both diabetic and non-diabetic patients,” J. Int. Oral Health, vol. 7, no. 8, pp. 70-76, 2015.
  20. N. Moussio, B. Jemea, J. Bayiha, M. EpackaEwane and B. NgoNonga, “Prevalence de l’arteriopathie obliterante des membres inferieurs chez les patients diabetiques a l’hopital general de Douala,” Health Sci. Dis., vol. 22, no. 4, pp. 29-34, 2021.
  21. B. J. Patel, D. N. Mehta, A. Vaghani and K. Patel, “Correlation of body mass (BMI) with saliva and blood glucose levels in diabetic and non-diabetic patients,” J. Pharmacy Bioallied Sci., vol. 15, no. 2, pp. s1204-s1207, 2023.
  22. S. Al-Shaheeb, H. K. Hashim, A. K. Mohammed, A. Al-Mashhadani and A. Al-Fandi, “Assessment of lipid profile with HbA1c in type 2 diabetic Iraqi patients,” Revis. Bionatura, vol. 7, no. 3, pp. 29-33, 2022.
  23. A. M. Habeeb, A. M. Al-Sarray and A. H. Al-Hafidh, “Lipid profiles and HbA1c level among type 2 diabetes patients in Hilla city Iraq,” J. Popul. Ther. Clin. Pharmacol., vol. 30, no. 7, pp. 273-278, 2023.
  24. I. M. Artha, A. Bhargah, N. K. Dharmawan, U. W. Pande, K. A. Triyana, P. A. Mahariski et al., “High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type 2 diabetes mellitus,” Vasc. Health Risk Manag., vol. 15, pp. 149-157, 2019.
  25. K. Stoberock, M. Kaschwich, S. Nicolays, N. Mahmoud, F. Heidemann and H. C. Rieb et al., “The interrelationship between diabetes mellitus and peripheral arterial diseases,” Vasa, vol. 50, no. 5, pp. 323-330, 2021.
  26. I. Bouragba, M. Diaf, S. Souiah, M. Asmaa and M. Attouya, “The association of glycated hemoglobin and lipid profile with peripheral artery disease in metabolic syndrome patients from Northwestern Algeria,” Baghdad Sci. J., vol. 21, no. 9, pp. 2820-2828, 2024.
  27. P. Song, D. Rudan, Y. Zhu, F. Fowkes, K. Rahimi and F. Fowkes et al., “Global, regional and national prevalence and risk factors for peripheral artery disease in 2015: An updated systematic review and analysis,” Lancet Glob. Health, vol. 7, no. 8, pp. 1020-1030, 2019.
  28. K. Mohammedi, M. Woodward, Y. Hirakawa, S. Zoungas, B. Williams and L. Lisheng et al., “Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes,” Diabetes Care, vol. 39, no. 10, pp. 1796-1803, 2016.
  29. H. K. Abdullah, “Selected salivary redox biomarkers and amylase gene (AMY1) copy number in relation to oral health status in insulin resistance and type two diabetic patients (a case control study),” MSc thesis, University of Baghdad, College of Dentistry, Baghdad, Iraq, 2024.
  30. G. Pendyala, B. Thomas and S. Joshi, “Evaluation of total antioxidant capacity of saliva in type 2 diabetic patients with and without periodontal disease: A case-control study,” North American Journal of Medical Sciences, vol. 5, no. 1, pp. 51-57, 2013.
  31. S. Porovic, H. Juric and S. Dinarevic, “Oxidative status of saliva and plasma in diabetic children,” vol. 11, no. 2, pp. 169-173, 2017.
  32. C. A. Juan, J. M. Perez, F. J. Plou and E. P. Lebena, “The chemistry of reactive oxygen species (ROS) revisited: Outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies,” vol. 22, no. 9, pp. 4642-4662, 2021.

Proceedings of the International Conference on Applied Innovations in IT by Anhalt University of Applied Sciences is licensed under CC BY-SA 4.0  ·  This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License

ICAIIT 2026
International Conference on Applied Innovation in IT
Navigation
Publisher
ISSN2199-8876
Publisher Edition Hochschule Anhalt
Location Anhalt University of Applied Sciences
Email leiterin.hsb@hs-anhalt.de
Phone +49 (0) 3496 67 5611
Address Building 01, Room 425
Bernburger Str. 55
D-06366 Köthen, Germany
Open Access License
CC BY-SA 4.0

All works are licensed under the Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), unless otherwise noted.

Published by ICAIIT in cooperation with Anhalt University of Applied Sciences.

© 2026 ICAIIT — International Conference on Applied Innovations in IT. Anhalt University of Applied Sciences, Köthen, Germany.
Visitors: site traffic counter